Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004208 |
ID: | TCMBANKHE004208 |
植物拉丁名: |
|
功能与主治: | To eliminate phlegm, soften hard masses and dissolve lumps, and to cause diuresis./Goiter and tuberculosis, scrofula, bleeding, painful swollen testes, phlegm-rheum and edema, prevention of cataracts. |
药用植物名: | 昆布 |
药用部位: | dried thallus |
药味: | Cold; Salty |
经络: | Stomach; Liver; Kidney |
临床特征: | 1. Treat hypothyroidism caused by deficiency of iodine and also hyperthyroidism.2. Its component laminine is a hypotensive.3. Another component laminarin can lower the level of blood lipids. |
治疗类型: | 化痰药 |
TCM_ID_id: | 2156 |
SymMap_id: | 232 |
TCMSP_id: | 436 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000915 | Stearidonic acid | CHEBI:32389; (6Z,9Z,12Z,15Z)-Octadecatetraenoic acid; C16300; all-cis-octadeca-6,9,12,15-tetraenoic acid; (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoic acid; LMFA01030357; 111174-40-4; 20290-75-9; 6Z,9Z,12Z,15Z-octadecatetraenoic acid | C18H28O2 | 276.41 | CCC=CCC=CCC=CCC=CCCCCC(=O)O |
| TCMBANKIN001719 | lecithin | phosphatidylcholine; 1-Lignoceryl-2-eicsoic acid; 1-Lignoceryl-2-eicsoate; 1-Lignoceryl-2-eicsoatetraenoyl-sn-glycero-3-phosphocholine | C52H98NO7P | 880.3 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC |
| TCMBANKIN001973 | Butylbenzene | EINECS 203-209-7; NSC 8465; HSDB 7211; N4B; 19610_FLUKA; 19600_FLUKA; 104-51-8; InChI=1/C10H14/c1-2-3-7-10-8-5-4-6-9-10/h4-6,8-9H,2-3,7H2,1H; 1-Butylbenzene; n-Butylbenzene; 4-05-00-01033 (Beilstein Handbook Reference); Benzene, butyl-; AI3-00119; WLN: 4R; CHEBI:44194; BRN 1903395; NSC8465; 1-Phenylbutane; B90203_ALDRICH; 74296-32-5; 47322_SUPELCO | C10H14 | 134.22 | CCCCC1=CC=CC=C1 |
| TCMBANKIN002879 | arachidonic acid | (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid; cis-5,8,11,14-Eicosatetraenoic acid; 3435-81-2; 5Z,8Z,11Z,14Z-icosatetraenoic acid; cis,cis,cis,cis-5,8,11,14-Eicosatetraenoic acid; C00219; ACD; Arachidonsaeure; arachidonicacid; DTXSID40473870; (5Z,8Z,11Z,14Z)-Icosatetraenoic acid; ST069383; 93444-49-6; (14C)Arachidonic acid; NCGC00094608-04; 5,8,11,14-Eicosatetraenoic acid, labeled with carbon-14, (all-Z)-; A3555_SIGMA; 5Z,8Z,11Z,14Z-eicosatetraenoic acid; all-cis-5,8,11,14-eicosatetraenoic acid; IDI1_034009; ARACHIDONIC ACID, [1-14C]-; BSPBio_001539; NCGC00094608-02; NCGC00094608-03; AIDS045704; CHEBI:15843; NCGC00094608-01; (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid; cis-Delta(5,8,11,14)-eicosatetraenoic acid; A3925_SIGMA; ACM3435812; Spectrum5_001910; Arachidonic acid-carboxy-14C; A9673_SIGMA; LMFA01030001; AIDS-045704; 10931_FLUKA; <i>cis,cis,cis,cis</i>-5,8,11,14-Eicosatetraenoic Acid | C20H32O2 | 304.5 g/mol | CCCCCC=CCC=CCC=CCC=CCCCC(=O)O |
| TCMBANKIN004999 | 2-hexenyl benzoate | C13H16O2 | CCCC=CCOC(=O)C1=CC=CC=C1 | ||
| TCMBANKIN006943 | histamine | beta-Aminoethylglyoxaline; 3bu1; IDI1_002144; Bio1_000976; AIDS020252; Histamium; 2-(3H-imidazol-4-yl)ethanamine; Bio1_000487; 5-Imidazoleethylamine; 4-Imidazoleethylamine; NCGC00093371-03; Spectrum3_000452; BCBcMAP01_000250; KBio3_000854; L-histamine; 1H-Imidazole-4-ethanamine; Spectrum4_000960; BSPBio_001117; KBio2_003893; C00388; 2-(1H-imidazol-4-yl)ethanamine; KBio2_000457; KBioSS_000457; Histamine, Free Base; CCRIS 6535; SMR000059091; NSC33792; KBio2_003025; CHEBI:58432; 2-(4-Imidazolyl)ethylamine; BSPBio_002124; Istamina [Italian]; Ergamine; 2-(1H-imidazol-5-yl)ethylazanium; ZERO/004089; HSM; 4-(2-Aminoethyl)-1H-imidazole; Eramin; Spectrum_000845; CJ-15872; Histamine Base; histaminium; .beta.-Imidazolyl-4-ethylamine; histaminium cation; Bio1_001465; beta-Imidazolyl-4-ethylamine; NSC 33792; KBioGR_001580; 3rxh; SMP1_000151; WLN: T5M CNJ D2Z; Histamine [USAN]; Imidazole-4-ethylamine; beta-Aminoethylimidazole; Spectrum2_000665; KBioSS_001325; Ergotidine; KBio3_000853; 2-Imidazol-4-ylethylamine; SDCCGMLS-0066601.P001; 5-(2-Aminioethyl)-1H-imidazole; 2-(3H-imidazol-4-yl)ethylamine; peremin; A828600; 51-45-6; AIDS-020252; HSDB 3338; NCGC00015513-01; HISTAMINE; EINECS 200-100-6; KBio2_005593; Lopac0_000595; nchembio714-comp1; KBio1_000308; MLS000069447; CHEBI:18295; Lopac-H-7250; Ethylamine, 2-imidazol-4-yl-; KBio3_001344; Free histamine; IDI1_000308; H7125_SIGMA; 2-(1H-imidazol-4-yl)ethanaminium; KBioGR_000457; KBio2_006461; ST073926; 53290_FLUKA; FT-0669215; 2-(1H-imidazol-5-yl)ethylammonium; beta-aminothethylglyoxaline; Bio2_000389; Spectrum5_000796; SPBio_000729; Theramine; DivK1c_000308; KBio2_001325; NINDS_000308; NCGC00093371-04; Bio2_000869; Imidazole, 4-(2-aminoethyl)-; 2-(1H-imidazol-5-yl)ethanamine | C5H9N3 | 111.15 | C1=C(NC=N1)CCN |
| TCMBANKIN007139 | a-formy1-a-terthieny1 | ||||
| TCMBANKIN011381 | inokosterone | Callinecdysone A; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R,5R)-1,2,6-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; C16992; 15130-85-5; Inokosterone; i-nokosterone; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methyl-heptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R,5R)-1,2,6-trihydroxy-1,5-dimethylhexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; 23261-09-8; DTXSID30436277; C08819 | C27H44O7 | 480.6 g/mol | CC(CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)CO |
| TCMBANKIN011842 | alpha-terthrenyl methanol | ||||
| TCMBANKIN012443 | (E)-5-Decenol | EINECS 260-267-6; NCGC00164122-01; 56578-18-8; 5-Decen-1-ol, (5E)-; LMFA05000042; AI3-34645; dec-5-en-1-ol; decan-5-en-1-ol; 284726_ALDRICH; (E)-5-Decen-1-ol; 5-Decen-1-ol, (E)-; SBB008885; 5-decen-1-ol; (E)-dec-5-en-1-ol; ZINC02169460; EPA Pesticide Chemical Code 078038; trans-5-Decen-1-ol | C10H20O | 156.27 | CCCCC=CCCCCO |
| TCMBANKIN012470 | Demissine | demissine | C50H83NO20 | 1018.19 | CC1CCC2C(C3C(N2C1)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)C)C |
| TCMBANKIN012642 | alpha-Terthienyl methyl acetate | [5-(5-thiophen-2-ylthiophen-2-yl)thiophen-2-yl]methyl acetate; α-terthienyl methyl acetate; [5-[5-(2-thienyl)-2-thienyl]-2-thienyl]methyl acetate; acetic acid [5-[5-(2-thienyl)-2-thienyl]-2-thienyl]methyl ester; [5-(5-thiophen-2-ylthiophen-2-yl)thiophen-2-yl]methyl ethanoate | 320.48 | CC(=O)OCC1=CC=C(S1)C2=CC=C(S2)C3=CC=CS3 | |
| TCMBANKIN014626 | alginic acid | BG01094448; AC-11039; L932; XJKJWTWGDGIQRH-IOPJEYNBSA-N; MFCD00081309; MolPort-039-144-939; (2R,4R,5S,6S)-3-{[(2R,3S,4R,5S,6S)-6-CARBOXY-3,4-DIHYDROXY-5-METHOXYOXAN-2-YL]OXY}-4,5-DIHYDROXY-6-METHYLOXANE-2-CARBOXYLIC ACID; C14H22O12; AKOS015960402 | C14H22O12 | 382.32 g/mol | CC1C(C(C(C(O1)C(=O)O)OC2C(C(C(C(O2)C(=O)O)OC)O)O)O)O |
| TCMBANKIN014984 | ecliptine | ||||
| TCMBANKIN018259 | Felosan | 3-(Methylcarbamoyl)pyridine; N-methylpyridine-3-carboxamide; N-Methylnicotinamide; Nicotinamide, N-methyl- (8CI); ZINC00404444; N -Methyl nicotineamide; 3-Pyridinecarboxamide, N-methyl- (9CI); SR 4415; NSC66521; 3-Pyridinecarboxamide, N-methyl-; EINECS 204-046-4; 114-33-0; NSC 66521; N-Methyl-3-pyridinecarboxamide; Nicotinic acid methylamide; Nicotinamide, N-methyl-; 3-(N-Methylcarbamoyl)pyridine | C7H8N2O | 136.15 | CNC(=O)C1=CN=CC=C1 |
| TCMBANKIN018789 | eckol | 88798-74-7; CHEMBL471187; 1-(3,5-Dihydroxyphenoxy)-2,4,7,9-tetrahydroxydibenzo-1,4-dioxin; 4-(3,5-dihydroxyphenoxy)-dibenzo(b,e)(1,4)dioxin-1,3,6,8-tetrol; D08MZY; Dibenzo[b,e][1,4]dioxin-1,3,6,8-tetrol, 4-(3,5-dihydroxyphenoxy)-; DTXSID40237333; ZINC6091359; 4-(3,5-dihydroxyphenoxy)oxanthrene-1,3,6,8-tetrol; AC1L3S7Z; BDBM50259982; CHEBI:65819; AIDS209851; Eckol; SCHEMBL2562621; Dibenzo(b,e)(1,4)-dioxin-1,3,6,8-tetrol, 4-(3,5-dihydroxyphenoxy)-; AIDS-209851; 4-(3,5-dihydroxyphenoxy)dibenzo-p-dioxin-1,3,6,8-tetrol | C18H12O9 | 372.28 | C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C=C4O3)O)O)O)O)O |
| TCMBANKIN019755 | 2,4-octanedione | C8H14O2 | 142.2 g/mol | CCCCC(=O)CC(=O)C | |
| TCMBANKIN024191 | 14-heptacosanol | C27H56O | 396.7 g/mol | CCCCCCCCCCCCCC(CCCCCCCCCCCCC)O | |
| TCMBANKIN025687 | Thiamine | (Riboflavin); thiamine; thiamine chloride; vitamin b1 | C12H18Cl2N4OS | 337.3 g/mol | [H+].CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.[Cl-].[Cl-] |
| TCMBANKIN026259 | testosterone | SR-05000001542-1; Spectrum4_000114; AB00053134_04; KBioSS_001813; Spectrum2_001799; HMS2091C05; IDI1_000744; KBioGR_000468; Spectrum_001333; MLS002554341; SR-05000001542; AC1NWAJL; KBio2_006949; SBI-0052631.P003; NCGC00178631-01; NSC-755838; SCHEMBL2600415; NINDS_000744; CHEMBL67934; SPECTRUM307023; (10R,13S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; KBio2_004381; SMR001475622; HMS502F06; CCG-39734; KBio1_000744; Spectrum3_000787; NSC755838; BSPBio_002494; Spectrum5_001759; BRD-A55393291-001-02-4; DivK1c_000744; SPBio_001757; KBio2_001813; Pharmakon1600-00307023; HMS3088I14; KBio3_001714 | C19H28O2 | 288.4 g/mol | CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C |
| TCMBANKIN026440 | ω-hexadecenoicacid | C16H30O2 | |||
| TCMBANKIN026694 | 2,4-Hexadiene, 3,4-dimethyl-, (E,Z)- | (2E,4Z)-3,4-dimethylhexa-2,4-diene; 2417-88-1; (E),(Z)-(CH3CH=C(CH3))2 | C8H14 | 110.2 | CC=C(C)C(=CC)C |
| TCMBANKIN027864 | Ecliptasaponin B | ecliptasaponin b; AC1O3D8J; [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 10-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | 959.26 | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)O)O)O)O)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C | |
| TCMBANKIN028197 | 1553-41-9 | Bio1_000230; (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoic acid; icosa-5,8,11,14,17-pentaenoic acid; KBioSS_000048; KBio3_000095; CBiol_001944; Bio1_000719; KBio2_000048; KBio2_005184; 5,8,11,14,17-EICOSAPENTAENOIC ACID; Bio2_000528; KBio3_000096; KBioGR_000048; LMFA01030181; KBio2_002616; 5, 8, 11, 14, 17-icosapentaenoic acid; Bio2_000048; Bio1_001208 | C20H30O2 | 302.45 | CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O |
| TCMBANKIN031757 | laminarin | C00771; SCHEMBL17408801; Laminarin; 9008-22-4; Laminaran; ZINC8551225 | C18H32O16 | 504.4 g/mol | C(C1C(C(C(C(O1)O)O)OC2C(C(C(C(O2)CO)O)OC3C(C(C(C(O3)CO)O)O)O)O)O)O |
| TCMBANKIN032396 | 5-(3d--2c- allyl methyl)furan-8-methoxy-coumarin | ||||
| TCMBANKIN034141 | edulinine | C16H21NO4 | 291.34 g/mol | CC(C)(C(CC1=C(C2=CC=CC=C2N(C1=O)C)OC)O)O | |
| TCMBANKIN034366 | 2-(buta-1,3-diynyl)-5-(but-3-en-1-ynyl) thiophene | 2-buta-1,3-diynyl-5-but-3-en-1-ynylthiophene; 2-(buta-1,3-diynyl)-5-(but-3-en-1-ynyl)thiophene; 2-(1,3-Butadiynyl)-5-(3-butene-1-ynyl)thiophene; AC1NST6R | C12H6S | 182.24 g/mol | C=CC#CC1=CC=C(S1)C#CC#C |
| TCMBANKIN036810 | Butein | 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 2′,4′,3,4-Tetrahydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-; NCGC00163519-01; (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; NSC652892; AIDS057944; AC1NST6X; AIDS-057944; 3,4,2',4'-Tetrahydroxychalcone; ST5331397; 2',3,4,4'-Tetrahydrochalcone; 2',3,4,4'-Tetrahydroxychalcone; B178_SIGMA; butein ; MolMap_000005; Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI); EINECS 207-659-5; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-; C08578; butein; 2',4',3,4-Tetrahydroxychalcone; 2′,3,4,4′-Tetrahydroxychalcone; Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihydroxyphenyl)-; NCI60_018489; HSCI1_000162; 21849-70-7; (Z)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 487-52-5; 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one | C15H12O5 | 272.25 | C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O)O |
| TCMBANKIN036828 | Wedelolactone | NCGC00163667-01; N2131; UNII-0K6L725GNS; 1,8,9-Trihydroxy-3-methoxycoumestan; Ambotz524-12-9; CTK8G3781; 0K6L725GNS; Wedelolactone, European Pharmacopoeia (EP) Reference Standard; SC-67595; ZINC6483512; IKK Inhibitor II, Wedelolactone; GTPL5551; CCG-208289; NCGC00163667-02; SR-05000002318-2; Wedelolactone, >=98% (HPLC), powder; 7-Methoxy-5,11,12-trihydroxy-coumestan; AKOS015897173; AN-45548; C10541; AC1NQZ4Z; CHEMBL97453; BRD-K53635676-001-02-3; 1,8,9-Trihydroxy-3-methoxy-benzo[4,5]furo[3,2-c]chromen-6-one; 7-Methoxy-5,11,12-trihydroxycoumestan; CHEBI:10037; DTXSID60200408; 1,8,9-trihydroxy-3-methoxy-6-benzofurano[3,2-c]chromenone; W4016_SIGMA; Wedelolactone, <i>Eclipta alba; FT-0698529; SCHEMBL601220; MFCD07778564; SR-05000002318; CM-842; 5,11,12-Trihydroxy-7-methoxycoumestan; K00058; 1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one; NCGC00163667-03; Wedelolactone, Eclipta alba; BRD-K53635676-001-01-5; 7-methoxy-5,11,12-trihydroxy-coumestan; Wedelolactone; 524W129; SMP2_000112; 1,8,9-trihydroxy-3-methoxy-benzofurano[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-methoxy-[1]benzofuro[3,2-c]chromen-6-one; 524-12-9; MolPort-003-960-187; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,8,9-trihydroxy-3-methoxy-; 1,8,9-trihydroxy-3-methoxy-benzofuro[3,2-c]chromen-6-one; HMS2043P19; LMPK12090046; D0F8QJ; BDBM50096619; Wedelolactone, analytical standard; I07-0266; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,1,8,9-trihydroxy-3-methoxy-; 1,8,9-Trihydroxy-3-methoxy-6H-[1]benzofuro[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-methoxy-[1]benzoxolo[3,2-c]chromen-6-one; Wedelolactone; 7-Methoxy-5,11,12-trihydroxy-coumestan | C16H10O7 | 314.246 | c1(O[H])c([H])c(c(C(=O)Oc(c([H])c(OC([H])([H])[H])c([H])c2O[H])c23)c3o4)c4c([H])c1O[H] |
| TCMBANKIN036879 | fucoxanthin | fucoxanthin | C42H58O6 | 658.9 g/mol | CC(=CC=CC=C(C)C=CC=C(C)C(=O)CC12C(CC(CC1(O2)C)O)(C)C)C=CC=C(C)C=C=C3C(CC(CC3(C)O)OC(=O)C)(C)C |
| TCMBANKIN036901 | myristic acid | 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 | C14H28O2 | 228.371 | C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN037143 | ecdysterone | 2beta,3beta,14alpha,20beta,22,25-Hexahydroxy-7-cholesten-6-one; ZINC04165898; ST5412041; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; AIDS-013374; AIDS013374; CHEMBL1707235; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R)-1,2,5-trihydroxy-1,5-dimethylhexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; HMS2225F24; SMR001397251; beta-Ecdysone; (2Beta,3beta,5beta)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one; H5142_SIGMA; 20-Hydroxyecdysone; SCHEMBL19213295; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methyl-heptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; 20-OH ecdysone; Ecdysterone; Insect moulting hormone; 20E; 2,3,14-Trihydroxy-10,13-dimethyl-17-(1,2,5-trihydroxy-1,5-dimethyl-hexyl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-6-one; MLS002473159; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R)-1,2,5-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (22R)-2beta,3beta,14alpha,20,22,25-hexahydroxy-5beta-cholest-7-en-6-one; 5289-74-7; CHEBI:16587 | C27H44O7 | 481 | [C@@]1([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@](C([H])([H])[H])(O[H])[C@]([H])(O[H])C([H])([H])C([H])([H])C(O[H])(C([H])([H])[H] )C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]23O[H])C3=C([H])C4=O)[C@@]4([H])C([H])([H])[C@@]1([H])O[H] |
| TCMBANKIN040593 | Eclalbasaponin XIII | ||||
| TCMBANKIN043561 | Laminine | AC1L98PS; FT-0695852; delta-trimethyllysine; N-EPSILON,N-EPSILON,N-EPSILON-TRIMETHYLLYSINE; S)-5-amino-5-carboxy-N,N,N-trimethyl-1-pentanaminium; 23284-33-5; Trimethyllysine; (S)-2-amino-6-(trimethylammonio)hexanoic acid; C-53472; C03793; AKOS006272412; N6,N6,N6-Trimethyl-L-lysine; N(6),N(6),N(6)-trimethyl-L-lysine; (S)-2-amino-6-(trimethylammonio)hexanoate; (2S)-2-amino-6-(trimethylazaniumyl)hexanoate | 189.28 g/mol | ||
| TCMBANKIN043655 | Chloromaloside | chloromaloside | C61H100O32 | 1243.34 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C(=O)[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])[C@@](O[H])(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C([H])([H])O [C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)O3)[C@]3([H])C4([H])[H])[C@]45[H])[C@@]5([H])C([H])([H])C6([H])[H])[C@@]6([H])C([H])([H])[C@@]1([H])O[C@@]7([H])[ C@]([H])(O[C@@]8([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O8)[C@@]([H])(O[H])[C@@]([H])(O[C@@]9([H])[C@]([H])(O[C@@]%10([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])( O[H])C([H])([H])O%10)[C@@]([H])(O[C@@]%11([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O%11)[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O9)[C@@]([H])(C([H])([H])O[H])O7 |
| TCMBANKIN046015 | saringosterol | Saringosterol; 24-vinyl-cholest-5-ene-3beta,24-diol; LMST01040167; CHEMBL252366 | C29H48O2 | 429 | C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@](O[H])(C([ H])=C([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]34[H])C([H])([H])[C@@]1([H])O[H] |
| TCMBANKIN047329 | Isodesacetyluvaricin | isodesacetyluvaricin; CHEMBL484529 | C37H66O6 | 606.9 g/mol | CCCCCCCCCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCCCCCC3=CC(OC3=O)C)O)O |
| TCMBANKIN047646 | eclalbasaponin xii | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 10-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxysulfonyloxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate; AC1O3D8D | C48H78O22S | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C)OC6C(C(C(C(O6)CO)O)O)OS(=O)(=O)OC7C(C(C(C(O7)CO)O)O)O)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C | |
| TCMBANKIN048217 | Phlorofucofuroeckol A | 5,8,13-Trioxaindeno[1,2-a]anthracene-1,3,6,10,12-pentol, 4,9-bis(3,5-dihydroxyphenoxy)-; 128129-56-6; 1,11-Di-(3,5-dihydroxyphenoxy)benzofuro(3,2-a)dibenzo(b,e)(1,4)-dioxin-2,4,8,10,14-pentaol; Benzo(b)benzofuro(3,2-f)(1,4)benzodioxin-1,3,6,10,12-pentol, 4,9-bis(3,5-dihydroxyphenoxy)-; AIDS-209854; AIDS209854; phlorofucofuroeckol a | 602.46 | ||
| TCMBANKIN048494 | Eclalbasaponin XI | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 10-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-ethoxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate; AC1O3D8A | |||
| TCMBANKIN049148 | beta-ionone | (E)-4-(2,6,6-trimethyl-1-cyclohexenyl)but-3-en-2-one; (Z)-4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-one; BB_NC-0321; 4-(2,6,6-Trimethylcyclohex-1-ene-1-yl)-but-3-ene-2-one; NSC 402758; beta-Cyclocitrylideneacetone; SCHEMBL813343; AIDS-032326; AIDS032326; EINECS 238-969-9; 4-(2,6,6-trimethyl-1-cyclohexenyl)but-3-en-2-one; .beta.-Cyclocitrylideneacetone; 4-(2,6,6-Trimethyl-1-cyclohexenyl)-3-buten-2-one; W259500_ALDRICH; 4-(2,6,6-Trimethyl-1-cyclohexen-l-yl)-3-buten-2-one; NSC46137; WLN: L6UTJ A1U1V1 B1 F1 F1; e-4-(2,6,6-trimethyl-cyclohexyl)-but-3-en-2-one; LS-871; EINECS 252-325-4; YJRODKCOICMRBO-BQYQJAHWSA-N; LS-47337; 35031-06-2; ST5306954; trans-.beta.-Ionone; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (E); IONONE, BETA; EINECS 252-912-5; β- Ionone; 58180_FLUKA; (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one; 4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-one; .beta.-Ionone isomer # 1; C12287; NSC402758; (3E)-4-(2,2,6-TRIMETHYLCYCLOHEXYL)BUT-3-EN-2-ONE; 14901-07-6; 4-(2,6,6-Trimethyl-2(1)-cyclohexen-1-yl)-3-buten-2-one; .beta.-Ionone isomer # 2; SCHEMBL813341; Dihydroionone; ZINC03881456; AC1O5BV0; Ionone, .beta.-; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (3E)-; CCRIS 6249; (E)-4-(2,2,6-trimethylcyclohexyl)but-3-en-2-one; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (E)-; I12603_ALDRICH; InChI=1/C13H20O/c1-10-6-5-9-13(3,4)12(10)8-7-11(2)14/h7-8H,5-6,9H2,1-4H3/b8-7; β-ionone; W259519_ALDRICH; .beta.-Ionone; beta-Ionone; 79-77-6; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-; .beta.-Ionene; 4-(2,2,6-Trimethylcyclohexyl)-3-buten-2-one; 36208-32-9 | C13H20O | 192.297 | C1([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C(\C([H])=C([H])\C(=O)C([H])([H])[H])=C(C([H])([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN049984 | alpha-Terithenyl acetate | C15H12O2S3 | 320.45 | c1(C([H])([H])OC(=O)C([H])([H])[H])sc(c2sc(c3sc([H])c([H])c3[H])c([H])c2[H])c([H])c1[H] | |
| TCMBANKIN050149 | 2,6-NONADIENOL | EINECS 227-394-9; 2,6-Nonadien-1-ol; nona-2,6-dien-1-ol; Cucumber alcohol; 2,6-Nonadien-1-ol, (2E,6Z)-; (E,Z)-2,6-nonadienol; AI3-36036; 28069-72-9; (2E,6E)-Nona-2,6-dien-1-ol; (2E,6Z)-Nona-2,6-dien-1-ol; FEMA No. 2780; EINECS 248-816-8; 5820-89-3; 2,6-nonadienol; 2-trans-6-cis-Nonadien-1-ol; 2,6-Nonadien-1-ol, (E,Z)-; Violet-leaf alcohol; (E,Z)-2,6-Nonadien-1-ol; 7786-44-9; ZINC02012062; EINECS 232-097-2 | C9H16O | 140.22 | CCC=CCCC=CCO |
| TCMBANKIN057947 | glucoside | SCHEMBL25601; FT-0626726; 136760-05-9; .beta.-D-Glucose; UNII-J4R00M814D; beta-glucose; 207381-EP2280021A1; 133947-06-5; beta-delta-Glucopyranose; MCULE-4260589665; CHEBI:15903; beta-d-(+)-glucose; BDBM50240803; 28905-12-6; MolPort-006-111-449; KB-277820; DB02379; D07ONX; 6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrol; SC-25121; NSC759603; (1->6)-beta-D-glucopyranan; 1,2-beta-D-Glucan; EINECS 207-756-2; beta-D-Glc; (1,2-beta-D-glucosyl)n; (2R,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; .beta.-D-Glucopyranose; FT-0622903; NSC-759603; Beta-D-glucose anhydrous; b-D-Glucopyranose; CHEMBL1614854; beta-D-glucopyranose; W-202206; 1,5]; AC1L21QQ; C00221; Grape sugar; BG01505598; Galactitol,1,5-anhydro-1-C-phenyl-; G0047; 53991-51-8; 492-61-5; b-d-glucose; 9001-37-0; BGC; WQZGKKKJIJFFOK-VFUOTHLCSA-N; (1->3)-beta-D-glucan; CTK8F0914; AKOS016010209; DB-051616; AE-562/43459286; 207381-EP2280004A1; 50986-29-3; AK306225; (1->3)-beta-D-glucopyranan; TR-038298; beta-(1,3)-glucan; Curdlan; b-Glucose; .beta.-d-Glucose, anhydrous; ZINC3833800; CHEBI:27517; CHEBI:37671; FCH1120200; beta-Dextrose; (1->4)-beta-D-glucopyranan; (1->6)-beta-D-glucan; WURCS=1.0/1,0/[12122h; beta-D-glucose; (2R,3R,4S,5R,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol; (1->2)-beta-D-glucopyranan; Pharmakon1600-01300015; ZYMOSAN; AJ-45802; (+)-Glucose; CHEBI:18246; 207381-EP2280020A1; (1->2)-beta-D-glucan; b-Dextrose; 108942-17-2; (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol; MFCD00063989; 492-64-8; CHEBI:27380; (1->4)-beta-D-glucan; anhydrous glucose; Glucose, (beta-D)-Isomer; J4R00M814D; Callose; beta-D-Glucopyranose, anhydrous; Beta-d-glucose, anhydrous; 128009-02-9; AX8115243;BGC | C6H12O6 | 180.16 g/mol | C(C1C(C(C(C(O1)O)O)O)O)O |
| TCMBANKIN058082 | 4-(3,5-dihydroxyphenoxy)-9-[6-(3,5-dihydroxyphenoxy)-2,4,7,9-tetrahydroxyoxanthren-1-yl]oxanthrene-1,3,6,8-tetrol | (1,1'-Bidibenzo(b,e)(1,4)dioxin)-2,2',4,4',7,7',9,9'-octol, 6,6'-bis(3,5-dihydroxyphenoxy)-; 88095-81-2; 6,6'-Bieckol; 4-(3,5-dihydroxyphenoxy)-9-[6-(3,5-dihydroxyphenoxy)-2,4,7,9-tetrahydroxy-oxanthren-1-yl]oxanthrene-1,3,6,8-tetrol; 4-(3,5-dihydroxyphenoxy)-9-[6-(3,5-dihydroxyphenoxy)-2,4,7,9-tetrahydroxy-1-oxanthrenyl]oxanthrene-1,3,6,8-tetrol | C36H22O18 | 742.55 | C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C(=C4O3)C5=C6C(=C(C=C5O)O)OC7=C(O6)C(=CC(=C7OC8=CC(=CC(=C8)O)O)O)O)O)O)O)O)O |
| TCMBANKIN058085 | 8,8'-bieckol | 9-(3,5-dihydroxyphenoxy)-2-[9-(3,5-dihydroxyphenoxy)-1,3,6,8-tetrahydroxy-2-oxanthrenyl]oxanthrene-1,3,6,8-tetrol; (2,2'-Bidibenzo(b,e)(1,4)dioxin)-1,1',3,3',6,6',8,8'-octol, 9,9'-bis(3,5-dihydroxyphenoxy)-; 8,8'-Bieckol; [2,2'-Bidibenzo[b,e][1,4]dioxin]-1,1',3,3',6,6',8,8'-octol, 9,9'-bis(3,5-dihydroxyphenoxy)-; 89445-12-5; AIDS209852; 9-(3,5-dihydroxyphenoxy)-2-[9-(3,5-dihydroxyphenoxy)-1,3,6,8-tetrahydroxy-oxanthren-2-yl]oxanthrene-1,3,6,8-tetrol; AIDS-209852;9-(3,5-dihydroxyphenoxy)-2-[9-(3,5-dihydroxyphenoxy)-1,3,6,8-tetrahydroxyoxanthren-2-yl]oxanthrene-1,3,6,8-tetrol | C36H22O18 | 742.55 | C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(O3)C=C(C(=C4O)C5=C(C6=C(C=C5O)OC7=C(O6)C(=C(C=C7O)O)OC8=CC(=CC(=C8)O)O)O)O)O)O)O |
| TCMBANKIN058088 | isodemethylwedelolactone | Isodemethylwedelolacton; 2,4,8,9-tetrahydroxy-[1]benzofuro[3,2-c]chromen-6-one; Isodemethylwedelolactone; AC1NSWZZ; 350681-33-3; ZINC14726551; isodemethylwedelo lactone; MolPort-039-339-151 | C15H8O7 | 300.22 g/mol | C1=C(C=C(C2=C1C3=C(C4=CC(=C(C=C4O3)O)O)C(=O)O2)O)O |
| TCMBANKIN058090 | demethylwedelolactone | 3,5,13,14-tetrahydroxy-8,17-dioxatetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one; C15H8O7; KB-216382; AKOS015897135; desmethylwedelolactone; MolPort-005-945-584; I07-0296; 1,3,8,9-Tetrahydroxy-6H-benzofuro[3,2-c]chromen-6-one; AC1NURC5; FT-0698755; 468D559; 4CH-024768; Demethylwedelolactone; CHEMBL2089002; DTXSID00214968; 3,5,13,14-TETRAHYDROXY-8,17-DIOXATETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(10),2(7),3,5,11(16),12,14-HEPTAEN-9-ONE; Norwedelolactone; 6468-55-9; AJ-65335; BG01013426; demethyl wedelolactone; ZINC14726530; ST24036753; AX8245784; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,3,8,9-tetrahydroxy-; 1,3,8,9-tetrahydroxy-[1]benzofuro[3,2-c]chromen-6-one; 1,3,8,9-Tetrahydroxy-6H-benzofuro-[3,2-c]chromen-6-one; SCHEMBL3364302; LMPK12090041; 1,3,8,9-Tetrahydroxy-6H-benzofuro[3,2-c][1]benzopyran-6-one; 9902AB; AK120368;6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,3,8,9-tetrahydroxy-; 6468-55-9; 1,3,8,9-tetrahydroxy-6-benzofurano[3,2-c]chromenone; 1,3,8,9-tetrahydroxy-[1]benzoxolo[3,2-c]chromen-6-one;desmethylwedelolactone;demethylwedelolacton;1,3,8,9-tetrahydroxybenzofurano[3,2-c]chromen-6-one | C15H8O7 | 300.22 | C1=C(C=C2C(=C1O)C3=C(C4=CC(=C(C=C4O3)O)O)C(=O)O2)O |
| TCMBANKIN058091 | Demethylwedelolactone-7-glucoside | 1,8,9-trihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-[1]benzoxolo[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-6-benzofurano[3,2-c]chromenone; 1,8,9-trihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-benzofurano[3,2-c]chromen-6-one; demethylwedelolactone-7-glucoside; 1,8,9-trihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-benzofurano[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-[1]benzofuro[3,2-c]chromen-6-one; AC1O3D6A | C21H18O12 | 462.39 | C1=C(C=C2C(=C1O)C3=C(C4=CC(=C(C=C4O3)O)O)C(=O)O2)OC5C(C(C(C(O5)CO)O)O)O |
| TCMBANKIN058113 | Butein | 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 2′,4′,3,4-Tetrahydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-; NCGC00163519-01; (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; NSC652892; AIDS057944; AC1NST6X; AIDS-057944; 3,4,2',4'-Tetrahydroxychalcone; ST5331397; 2',3,4,4'-Tetrahydrochalcone; 2',3,4,4'-Tetrahydroxychalcone; B178_SIGMA; butein ; MolMap_000005; Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI); EINECS 207-659-5; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-; C08578; butein; 2',4',3,4-Tetrahydroxychalcone; 2′,3,4,4′-Tetrahydroxychalcone; Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihydroxyphenyl)-; NCI60_018489; HSCI1_000162; 21849-70-7; (Z)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 487-52-5; 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one | C15H12O5 | 272.25 | C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O)O |
| TCMBANKIN058448 | .alpha.-T OHMe deriv. | 2,2':5',2''-Terthien-5-ylmethanol; AIDS-005099; [5-(5-thiophen-2-ylthiophen-2-yl)thiophen-2-yl]methanol; [5-[5-(2-thienyl)-2-thienyl]-2-thienyl]methanol; AIDS005099; alpha-Terthienyl methanol; α-terthienyl methanol; a-terthienylmethanol | C13H10OS3 | 278.4 g/mol | C1=CSC(=C1)C2=CC=C(S2)C3=CC=C(S3)CO |
| TCMBANKIN058535 | butin | ACon1_000269; MolPort-001-740-173; 4CN-1039; MCULE-9899038190; BRD-A75085792-001-01-8; MEGxp0_000004; AC1MRPVU; 21913-99-5; SCHEMBL5504140; 3',4',7-Trihydroxyflavanone; NCGC00180724-01; NP-000008; 2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrochromen-4-one; CHEMBL3401430 | C27H30O16 | 610.52 | C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC(=C(C=C3)O)O |
| TCMBANKIN058667 | 2-(4-chloro-3-hydroxy-1-butynyl)-5-(1,3-pentadiynyl)thiophene | 2-(4-chloro-3-hydroxybut-1-ynyl)-5-(penta-1,3-diynyl) thiophene; YSYBCKHAFOAQDX-UHFFFAOYSA-N; AK104297; MolPort-023-299-011; ST24037944; 1-chloro-4-(5-penta-1,3-diynylthiophen-2-yl)but-3-yn-2-ol; 1-CHLORO-4-[5-(PENTA-1,3-DIYN-1-YL)THIOPHEN-2-YL]BUT-3-YN-2-OL; BG00955026; 2-(4-Chloro-3-hydroxy-1-butynyl)-5-(1,3-pentadiynyl)thiophene; 2(-4-Chloro-3-hydroxy-1-butynyl)-5-1,(3-pentadiynyl)thiophene; 26905-70-4; AKOS022184879; 1-Chloro-4-[5-(1,3-pentadiynyl)-2-thienyl]-3-butyne-2-ol; W2371; 1-Chloro-4-(5-(penta-1,3-diyn-1-yl)thiophen-2-yl)but-3-yn-2-ol; AC1NSTJ2; 2-(4-chloro-3-hydroxybut-1-ynyl)-5-(penta-1,3-diynyl)thiophene; 4CN-0136; DTXSID60415691 | C13H9ClOS | 248.73 g/mol | CC#CC#CC1=CC=C(S1)C#CC(CCl)O |
| TCMBANKIN059249 | CLR | 5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N | C27H46O | 386.65 | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN059403 | Fucosterol | C29H48O | 412.7 g/mol | CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN059593 | Ecliptasaponin A | C36H58O9 | 634.84 | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)C(=O)O)C | |
| TCMBANKIN059717 | beta-Cyclocitral | C10H16O | 152.23 g/mol | CC1=C(C(CCC1)(C)C)C=O | |
| TCMBANKIN059908 | xylene | C8H10 | 106.17 | CC1=CC=C(C=C1)C.CC1=CC(=CC=C1)C.CC1=CC=CC=C1C | |
| TCMBANKIN059948 | Vitamin- G | C17H20N4O6 | 376.36 | CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O | |
| TCMBANKIN059985 | alpha-terpinol | C10H18O | 154.25 g/mol | CC1=CCC(CC1)C(C)(C)O | |
| TCMBANKIN060104 | paristerone | C27H44O7 | 480.6 g/mol | CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O | |
| TCMBANKIN060140 | friedelan-3-one | C30H50O | 426.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C | |
| TCMBANKIN060458 | cubenol | C15H26O | 222.37 | CC1CCC(C2C1(CCC(=C2)C)O)C(C)C | |
| TCMBANKIN060670 | 2-butanol | C4H10O | 74.12 g/mol | CCC(C)O | |
| TCMBANKIN060705 | methyl linoleate | C19H34O2 | 294.47 | CCC=CCC=CCC=CCCCCCCCC(=O)OC | |
| TCMBANKIN060789 | 2,4-octadienal | C8H12O | 124.18 g/mol | CCCC=CC=CC=O | |
| TCMBANKIN060790 | leaf aldehyde | C6H10O | 98.14 g/mol | CCCC=CC=O | |
| TCMBANKIN060853 | CHEBI:39932 | C8H16O | 128.21 | CCCCCC(C=C)O | |
| TCMBANKIN060868 | trans-2,4-decadienal | C10H16O | 152.23 g/mol | CCCCCC=CC=CC=O | |
| TCMBANKIN060873 | arachidonic acid | C20H32O2 | 304.5 g/mol | CCCCCC=CCC=CCC=CCC=CCCCC(=O)O | |
| TCMBANKIN060874 | Ligla; gamma-linolenic acid | C18H30O2 | 278.43 | CCCCCC=CCC=CCC=CCCCCC(=O)O | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060888 | caproaldehyde | C6H12O | 100.16 g/mol | CCCCCC=O | |
| TCMBANKIN060906 | trans-2-nonenal | C9H16O | 140.22 g/mol | CCCCCCC=CC=O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061029 | myristic acid | C14H28O2 | 228.37 | CCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061043 | MYS | C15H32 | 212.41 | CCCCCCCCCCCCCCC | |
| TCMBANKIN061105 | Eicosanoic acid | C20H40O2 | 312.53 g/mol | CCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061194 | 1-hexanol | C6H14O | 102.17 g/mol | CCCCCCO | |
| TCMBANKIN061371 | nicotine | 36733_RIEDEL; 2yk1; CHEBI:59806; 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine; (2S)-1-methyl-2-(pyridin-3-yl)pyrrolidinium; (S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE; D03365; 54-11-5; NCGC00090693-03; 46343_RIEDEL; C00745; Nicotine; NCGC00090693-04; AIDS-156031; 65-31-6 (R,R-BITARTRATE); (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine; (S)-3-(N-methylpyrrolidin-2-yl)pyridine; Habitrol (TN); SBB012359; N5511_SIGMA; (−)-Nicotine; Nicotine (compounds related to); PDSP2_000555; NCT; N3876_SIGMA; 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine; NCGC00090693-01; ZB012057; (S)-(-)-nicotine; CHEBI:17688; SDCCGMLS-0066911.P001; (S)-nicotinium(1+); AC1OCG5J; 3-(2-(N-methylpyrrolidinyl))pyridine; NSC97238 (R,R-BITARTRATE SALT); 3-[(2S)-1-methylpyrrolidin-1-ium-2-yl]pyridine; (S)-nicotinium cation; AIDS156031; NCGC00090693-05; PDSP1_000465; PDSP1_000113; PDSP2_000463; (S)-3-(1-methylpyrrolidin-2-yl)pyridine; Nicotine (USP); 54-11-5 (FREE BASE); L(-)-nicotine; (−)-Nicotine solution | C10H14N2 | 162.23 g/mol | CN1CCCC1C2=CN=CC=C2 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab